Viridian Therapeutics, Inc.\DE Cash Flow Statement (2013-2026) | VRDN

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-17.96M-14.04M-29.14M-25.69M-29.54M-28.94M-45.59M-68.19M-55.06M-47.66M-84.18M-57.69M-72.96M-91.49M-79.09M-94.16M-111.67M-35.05M-99.00M-111.76M
Share-based Compensation (Quarter)
3.82M3.98M-3.47M4.66M-4.66M14.49M-14.49M15.22M12.30M-21.82M61.48M12.69M11.77M8.72M-33.17M10.22M10.84M-20.34M-0.73M13.39M
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
Cash from Operations (Quarter)
-14.63M-11.88M-16.54M-21.04M-18.09M-20.67M-34.04M-61.97M-45.21M-38.98M-38.00M-45.22M-46.06M-67.71M-73.33M-92.65M-75.37M-84.61M-23.75M-119.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.25M-0.23M-0.25M-0.27M-0.26M-0.19M0.94M2.98M2.91M2.54M3.07M4.66M4.41M3.38M3.21M2.32M1.55M1.13M1.75M1.86M
Amortization of Deferred Charges (Quarter)
0.09M0.05M0.05M0.13M0.05M0.05M0.09M0.12M0.12M0.12M0.07M0.06M0.10M0.10M
Depreciation & Amortization (CF) (Quarter)
0.03M0.03M0.01M0.04M0.06M0.06M0.10M0.10M0.13M0.14M0.15M0.14M0.14M0.13M0.08M0.12M0.11M0.11M0.12M0.12M
Change in Working Capital
Change in Receivables (Quarter)
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
-1.11M1.46M-1.41M0.03M1.70M8.05M1.75M-6.65M-3.77M-0.11M-1.52M0.48M0.44M2.93M-3.92M1.76M4.63M1.55M-1.38M4.63M
Change in Accured Expenses (Quarter)
2.52M-5.93M1.63M0.48M5.48M-4.25M6.00M2.58M2.64M-5.03M4.53M-0.89M7.53M3.91M10.79M-15.90M6.18M4.61M21.32M-23.69M
Other Working Capital Changes (Quarter)
0.93M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M-0.07M
Investing Activities
Capital Expenditures (Quarter)
0.07M0.18M-0.25M0.18M-0.18M0.57M-0.19M0.12M0.33M0.40M0.05M0.10M0.29M0.11M0.09M0.04M0.13M0.24M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.07M0.00M0.00M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
-0.50M24.60M22.76M14.23M14.26M42.75M37.70M64.10M49.10M98.49M102.83M82.56M121.34M144.05M118.98M171.39M131.51M140.29M99.01M168.60M
Cash from Investing Activities (Quarter)
-11.21M6.25M-80.21M8.86M13.96M42.65M-180.60M-13.29M40.71M48.04M-169.71M-143.04M61.98M-84.67M-62.91M100.06M75.72M126.08M-339.42M77.26M
Financing Activities
Other financing activities (Quarter)
-0.94M0.94M-0.90M0.91M-0.72M0.95M8.12M-8.49M0.36M383.39M-378.40M1.62M-0.50M287.93M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
-0.45M0.45M-15.00M
Change in Capital Stock
Shares Issued (Quarter)
Net Equity Issued and Repurchased (Quarter)
32.40M32.40M44.00M24.20M15.26M35.20M1.06M-11.26M4.94M-0.14M9.80M63.15M
Dividend Payments
Dividends Paid - Common (Quarter)
Misc.
Cash from Financing Activities (Quarter)
7.05M116.79M0.17M0.74M4.56M290.93M26.01M8.20M3.07M15.46M198.94M177.08M0.11M245.02M35.52M9.21M0.76M10.86M405.91M6.36M
Change in Cash (Quarter)
-18.78M111.17M-96.58M-11.44M0.43M312.92M-188.63M-67.06M-1.43M24.52M-8.77M-11.19M16.03M92.65M-100.72M16.62M1.11M52.32M42.73M-36.04M
Free Cash Flow (Quarter)
-14.70M-12.06M-16.29M-21.22M-17.91M-21.23M-33.86M-62.09M-45.55M-39.39M-38.05M-45.22M-46.16M-68.00M-73.45M-92.74M-75.42M-84.74M-23.99M-119.68M
Net Cash Flow (Quarter)
-18.78M111.17M-96.58M-11.44M0.43M312.92M-188.63M-67.06M-1.43M24.52M-8.77M-11.19M16.03M92.65M-100.72M16.62M1.11M52.32M42.73M-36.04M